Aktia Bank Plc
Aktia Bank Plc
Stock Exchange Release
4 March 2021 at 4.15 p.m.
Aktia Bank Plc: Managers’ Transactions – Outi Henriksson
Person subject to the notification requirement
Name: Henriksson, Outi
Position: Chief Financial Officer
Issuer: Aktia Bank plc
LEI: 743700GC62JLHFBUND16
Notification type: INITIAL NOTIFICATION
Reference number: 743700GC62JLHFBUND16_20210303101550_50
____________________________________________
Transaction date: 2021-03-02
Venue not applicable
Instrument type: SHARE
ISIN: FI4000058870
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 1,510 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 1,510 Volume weighted average price: 0.00 EUR
Aktia Bank Plc
Further information:
Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587
Distribution:
Nasdaq Helsinki Ltd
Mass media
www.aktia.com
Aktia is a Finnish asset manager, bank and life insurer that has been creating wealth and wellbeing from one generation to the next for 200 years. We serve our customers in digital channels everywhere and face-to-face in our offices in the Helsinki, Turku, Tampere, Vaasa and Oulu regions. Our award-winning asset management business sells investment funds internationally. We employ approximately 830 people around Finland. Aktia's assets under management (AuM) on 31 December 2020 amounted to EUR 10.4 billion, and the balance sheet total was EUR 10.6 billion. Aktia's shares are listed on Nasdaq Helsinki Ltd (AKTIA). aktia.com.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
KH Group Oyj19.9.2025 14:20:51 CEST | Press release
Inside information: Carl Haglund appointed as CEO of KH Group Plc
F. Hoffmann-La Roche Ltd19.9.2025 14:15:00 CEST | Press release
CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma
Ipsen Pharma19.9.2025 13:59:15 CEST | Press release
Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC
Alvotech19.9.2025 13:45:00 CEST | Press release
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
Yacht Club de Monaco19.9.2025 13:11:39 CEST | Press release
At Yacht Club de Monaco the 5th Monaco Smart & Sustainable Marina Rendezvous
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom